We retrospectively reviewed the results of surgery in 27 Cytomegalovirus (CMV) and varicella zoster virus (VZV) retinitis are the two most common ocular manifestations in acquired immune deficiency syn drome (AIDS). Rhegmatogenous retinal detachment occurs in 17_34%1,2 and 70%3 of the involved eyes, respectively. Its incidence is increasing owing to the extension of patients' life expectancy. Preservation of visual function in these eyes requires control of the retinitis using active antiviral medication and man agement of the related retinal detachment.
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Extraocular explantation has failed to cure these rhegmatogenous retinal detachments,2, 4 ,5 which are related to small, multiple breaks, often posteriorly located, at the margins of or over the inactive retinitis. Laser photocoagulation around the detached area does not prevent the progression of subretinal fluid. 6 We retrospectively reviewed 27 consecutive cases of viral retinitis-related retinal detachment in AIDS patients. Vitrectomy and silicone oil tamponade with or without scleral buckling were performed in all cases. We analysed the anatomical and functional results after both surgical procedures.
PATIENTS AND METHODS
Twenty-seven eyes of 26 consecutive patients were included in the study between September 1993 and September 1995. Clinical diagnosis of CMV or VZV retinitis was established in 24 eyes and 3 eyes, respectively. Antiviral therapy for both types of retinitis consisted of intravenous ganciclovir (10 mg/ kg per day) or foscarnet (180 mg/kg per day) administered as an induction therapy when the retinitis was active, followed by a half-dose main tenance therapy when the lesions were healed. Intravitreous injections of 400 fLg of ganciclovir were performed in cases of systemic intolerance to intravenous medication. When necessary, they were continued post-operatively through a vitreous cavity filled with silicone oil.
Rhegmatogenous retinal detachments threatening or involving the macula were selected for surgery. Eyes presenting with preoperative optic atrophy or retinal necrosis involving the macula or the optic disc were excluded. Surgery was performed within the week following the diagnosis of retinal detachment. General anaesthesia was used for the first 21 procedures. The last 6 patients underwent surgery under local anaesthesia using a peribulbar injection of xylocaine 2%, bupivacaine 0.5% and hyaluroni dase.
A three-port pars plana vitrectomy with silicone oil tamponade was performed in 27 eyes. Two recurrent detachments after a previous extraocular procedure (1 eye) or vitrectomy with gas tamponade (1 eye) were included. Of the 27 operated eyes, two groups were identified: a first group (group 1) of 9 eyes was administered an encircling scleral buckle 5 mm wide and a second group of 18 eyes (group 2) did not have any explant associated with the intraocular pro cedure. If scleral buckling was applied, an intraoperative anterior chamber puncture was performed to prevent an excessive increase in the intraocular pressure. Ganciclovir (30 J-Lg/ml) was added to the balanced salt infusion solution in all cases. 14 The vitrectomy was performed as completely as possible. The posterior hyaloid was removed if not already detached. Epiretinal membranes were isolated and peeled. The retinal reattachment procedure consisted of perfluorocarbon liquid (per fluorodecalin, DK-line, Opsia) instillation through the vitreous cavity in 15 eyes and direct fluid-silicone oil exchange in the 12 remaining eyes. Complete endodrainage of subretinal fluid was carried out in all cases through existing breaks, or posterior retin otomy. Complete filling of the vitreous cavity with silicone oil (1.300 centistokes; Oxane, Opsia) was then achieved in all cases. Endophotocoagulation was applied to all visible retinal breaks, around drainage sites and at the margins of the retinitis area. Post-operative examination was performed at day 1, day 10, and twice a month thereafter. This included measurement of visual acuity, and the evaluation of D. HANNOUCHE ET AL.
retinal reattachment and retinitis activity. Silicone oil was left in the eye in all cases.
RESULTS
Twenty-two men and four women were included in the study. The mean age was 38 years (range 26-54 years). The CD4 lymphocyte count was less than 50 mm 3 in all cases. The mean follow-up period was 13 weeks (range 1-40 weeks).
Retinal detachment occurred after a mean period of 10 months in CMV retinitis and 3 weeks in VZV retinitis. It was bilateral in 19 cases (73 %). At the time of surgery, the retinitis was inactive in 16 eyes (59%). Intravenous ganciclovir and foscarnet had been administered to 16 patients (61 %) and 10 patients (39%), respectively. Intravitreous injections of ganciclovir had been performed preoperatively in 11 eyes (40%) and were continued post-operatively through a vitreous cavity filled with silicone oil in 5 eyes. No adverse events were reported in these latter cases.
The retinal detachment was bilateral in 7 cases (27%). It involved the macula in 22 eyes (82%). Preoperative proliferative vitreoretinopathy (PVR) of grade CPl or more was reported in 2 eyes (7%), 1 of which was a recurrent detachment. Multiple atrophic microholes were identified at the margins of the inactive retinitis areas in 23 eyes (85%). Preoperative posterior vitreous detachment was found in 12 eyes (45 %) and successful intraoperative removal of the attached posterior hyaloid was performed in the remaining 15 eyes (55%). No intraoperative arterial spasm was reported after perfluorocarbon liquid or silicone oil injection.
Results of surgery are summarised in Table I . Post operative flattening of the retina was achieved in all eyes. A recurrent detachment associated with PVR was reported in 1 eye (11 %) of group 1 with scleral buckling, after a 5 month period. No reintervention was performed. Shallow inferiorly located retinal detachments developed in 2 eyes of 18 (11 %) in group 2 without scleral buckling. No reintervention was periormeo since tbe retina) oetacbment did not extend beyond the inferior temporal vascular arcades during the follow-up period.
The Phacosclerosis developed in 8 eyes (29%), 2-8 months (mean 5 months) after surgery. Five eyes required cataract extraction during the first post operative year. Phacoemulsification with capsular bag implantation was successfully performed in these 5 cases. No silicone oil loss was reported after cataract surgery.
Progressive visual impairment related to optic atrophy occurred in 6 eyes (22%), 1-4 months after surgery. Two of these eyes had undergone scleral buckling.
Fourteen patients (54 %) died during the follow-up period. Their mean survival time was 5 months.
DISCUSSION
Rhegmatogenous retinal detachment associated with viral retinitis is a major cause of severe visual impairment in AIDS patients. AIDS patients are at high risk of blindness since the contralateral eye may experience retinal necrosis of the posterior pole, optic atrophy or rhegmatogenous retinal detachment in 46-67% of cases.15, 16 The incidence of retinal detachment in viral retinitis is related to the involvement of pre-equatorial retina2 and to the extent2,16 and duration of retinitis. It occurs over active15-17 or healed4 retinitis. Multiple posterior microholes, usually found at the junction between retinitis and uninvolved retina, require permanent internal tamponade which is best achieved by silicone oil tamponade.
We report here the results of vitrectomy and silicone oil tamponade, with or without scleral buckling, in eyes. presenting with rhegmatogenous retinal detachment involving the posterior pole.
At the time of the last visit, the rate of macular reattachment reached 89% in eyes with scleral buckling and 89% in eyes without scleral buckling.
these resu\ts are conslstent '\Nl\.\\ �re\jlO\lS s\.\l\l\es4,l\',, l9 which reported a final macular reattachment rate of 82-84 % after procedures excluding scleral buckling.
The systematic use of an encircling procedure in these eyes has been advocated to obtain a higher rate of total retinal reattachment,1l,12 reduction of sili cone-induced hyperopia18 and release of the vitreous base. Incomplete tamponade of inferior holes by silicone oil has justified the use of scleral buckling although the explant can not tamponade all the inferior necrotic area. lO We believe that the exclusion of scleral buckling from the procedure can be considered in these eyes because of the low rate of associated PVR. As the posterior hyaloid has been removed, post-operative PVR rarely develops?,6,10 This could be related to the alteration of immunity in AIDS patients. Scleral buckling can induce intraoperative variations in intraocular pressure with potential alteration of optic disc perfusion. Another advantage of excluding scleral buckling is the reduction of the intraoperative time. Shorter procedures allow the use of local anaesthesia without discomfort for the patients. This argument has to be considered in patients who are in poor general condition.
Inferior limited retinal detachments sometimes develop after vitrectomy and silicone oil tamponade without scleral buckling. They do not interfere with visual recovery since they involve necrotic retina and usually do not reach the posterior pole. In our series, these eyes did not require reintervention.
Despite poor visual outcome, 67% of the eyes retained a post-operative ambulatory vision (>5/200). An improvement of visual acuity of 2 Snellen lines or more was observed in 11 eyes (41%). Visual prognosis was unrelated to the intraoperative use of an encircling procedure. Although a small number of VZV cases was included, functional results seemed to be poorer in VZV retinitis than in CMV retinitis. VZV retinitis involved the macula more frequently and was commonly associated with optic atrophy.
Five eyes with macula-on retinal detachments were included in our series. These patients experi enced immediate post-operative deterioration of visual acuity due to silicone-oil-induced hyperopia. Therefore, we believe that surgery can be delayed until macular detachment occurs. If surgery is performed within a few days of macular detachment, vision usually recovers.
Optic atrophy was responsible for progressive secondary visual impairment in 22 % of the eyes in the 4 post-operative months. This complication may be attributed more to the extent of the retinitis itself than to the surgical procedure.
Post-operative reactivation of the retinitis with macular involvement remains a common cause of secondary visual loss 7 and requires the continuation of antiviral therapy post-operatively. We have administered intravitreous injections of ganciclovir through silicone oil as a maintenance therapy in 5 eyes of 5 patients who could not benefit from systemic medication. No relapse of retinitis was observed, and no adverse effect was reported. The efficacy of this procedure can not be assessed because of the small number of cases included. The diffusion of ganciclovir into the fluid surrounding the silicone oil bubble may, however, prevent a relapse of the retinitis.
This study c(;mfirms the efficacy of vitrectomy, posterior hyaloid peeling and silicone oil tamponade without scleral buckling in the management of viral retinitis-associated retinal detachments in AIDS. Our approach is to select for surgery eyes with recent macular detachment, with no preoperative optic atrophy or posterior pole necrosis. Surgery is recommended in these cases owing to the expected visual improvement. Since a short procedure exclud ing scleral buckling is performed, local anaesthesia should be preferred in these patients in poor general condition. Filling of the vitreous cavity with silicone oil does not seem to preclude the use of the intravenous route for antiviral therapy.
